Similar articles

• Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.

  Douketis JD, Arneklev K, Goldhaber SZ, Spandorfer J, Halperin F, Horrow J. Douketis JD, et al. Arch Intern Med. 2006 Apr 24;166(8):853-9. doi: 10.1001/archinte.166.8.853. Arch Intern Med. 2006. PMID: 16636210 Clinical Trial.
• Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

  Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L. Jacobs LG, et al. Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002. Am J Geriatr Pharmacother. 2009. PMID: 19616184
• Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.

  Mant JW. Mant JW. Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344. Thromb Haemost. 2008. PMID: 18612531 No abstract available.
• Atrial fibrillation: stroke prevention in older adults.

  Quinn GR, Fang MC. Quinn GR, et al. Clin Geriatr Med. 2012 Nov;28(4):617-34. doi: 10.1016/j.cger.2012.08.003. Clin Geriatr Med. 2012. PMID: 23101573 Review.
• Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients.

  Sellers MB, Newby LK. Sellers MB, et al. Am Heart J. 2011 Feb;161(2):241-6. doi: 10.1016/j.ahj.2010.11.002. Am Heart J. 2011. PMID: 21315204 Review.